Cardiac Transcriptome and Dilated Cardiomyopathy Genes in Zebrafish

Circulation: Cardiovascular Genetics

Volumn 8, Issue 2, 2015, Pages 261-269

  Shih, Yu Huan ^a   Zhang, Yuji ^e,f   Ding, Yonghe ^a   Ross, Christian A ^b   Li, Hu ^c   Olson, Timothy M ^c,d   Xu, Xiaolei ^a,d  

^a MAYO GRADUATE SCHOOL   (United States)

^b Information Technology   (United States)

^c Department of Molecular Pharmacology and Experimental Therapeutics ^*  (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

cardiomyopathy, dilated; fetal gene program; MYH6 7; transcriptome; zebrafish

Indexed keywords

ACTIN; ACTIN ALPHA CARDIAC MUSCLE 1; BCL2 ASSOCIATED ATHANOGENE 3; CAVEOLIN 3; DESMOCOLLIN 2; DNAJ (HSP40) HOMOLOG SUBFAMILY C MEMBER 19; DYSTROPHIN; EMERIN; EYES ABSENT HOMOLOG 4; FUKUTIN; GATA ZINC FINGER DOMAIN CONTAINING 1; INTEGRINLINKED KINASE; LAMIN A; LAMININ ALPHA4; LYSOSOMELAMP2 ASSOCIATED MEMBRANE PROTEIN 2; MUSCLE LIM PROTEIN; MYOPALLADIN; MYOSIN BINDING PROTEIN C; NEBULETTE; NEXILIN; PHOSPHOLAMBAN; PLAKOPHILIN; PLAKOPHILIN 2; PRESENILIN 1; PRESENILIN 2; PROTEIN; RNA BINDING PROTEIN; RNA BINDING PROTEIN 20; THE SUBUNIT SUR2A OF CARDIAC ATP SENSITIVE POTASSIUM CHANNEL; TRANSCRIPTOME; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; ZEBRAFISH PROTEIN;

ADULT; ANIMAL TISSUE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FISH GENETICS; GENE; GENE EXPRESSION; GENETIC IDENTIFICATION; LARVA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TRANSCRIPTOMICS; ZEBRA FISH; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; GENE EXPRESSION REGULATION; HUMAN; METABOLISM;

ANIMALS; BIOMARKERS; CARDIOMYOPATHY, DILATED; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; TRANSCRIPTOME; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84942909519     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.114.000702     Document Type: Article

References (47)

1. Muntoni F, Cau M, Ganau A, Congiu R, Arvedi G, Mateddu A, et al. Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med. 1993;329:921-925. doi: 10.1056/NEJM199309233291304.
2. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science. 1998;280:750-752.
3. McNally EM, Golbus JR, Puckelwartz MJ. Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest. 2013;123:19-26. doi: 10.1172/JCI62862.
4. Pugh TJ, Kelly MA, Gowrisankar S, Hynes E, Seidman MA, Baxter SM, et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med. 2014;16:601-608. doi: 10.1038/gim.2013.204.
5. Stainier DY, Fouquet B, Chen JN, Warren KS, Weinstein BM, Meiler SE, et al. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development. 1996;123:285-292.
6. Amsterdam A, Nissen RM, Sun Z, Swindell EC, Farrington S, Hopkins N. Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci USA. 2004;101:12792-12797. doi: 10.1073/pnas.0403929101.
7. Clark KJ, Balciunas D, Pogoda HM, Ding Y, Westcot SE, Bedell VM, et al. In vivo protein trapping produces a functional expression codex of the vertebrate proteome. Nat Methods. 2011;8:506-515. doi: 10.1038/nmeth.1606.
8. Delvecchio C, Tiefenbach J, Krause HM. The zebrafish: a powerful platform for in vivo, HTS drug discovery. Assay Drug Dev Technol. 2011;9:354-361. doi: 10.1089/adt.2010.0346.
9. Nasevicius A, Ekker SC. Effective targeted gene 'knockdown' in zebrafish. Nat Genet. 2000;26:216-220. doi: 10.1038/79951.
10. Campbell JM, Hartjes KA, Nelson TJ, Xu X, Ekker SC. New and TALENted genome engineering toolbox. Circ Res. 2013;113:571-587. doi: 10.1161/CIRCRESAHA.113.301765.
11. Xu X, Meiler SE, Zhong TP, Mohideen M, Crossley DA, Burggren WW, et al. Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin. Nat Genet. 2002;30:205-209. doi: 10.1038/ng816.
12. Sehnert AJ, Huq A, Weinstein BM, Walker C, Fishman M, Stainier DY. Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat Genet. 2002;31:106-110. doi: 10.1038/ng875.
13. Yang J, Xu X. ?-Actinin2 is required for the lateral alignment of Z discs and ventricular chamber enlargement during zebrafish cardiogenesis. FASEB J. 2012;26:4230-4242. doi: 10.1096/fj.12-207969.
14. Chen Z, Huang W, Dahme T, Rottbauer W, Ackerman MJ, Xu X. Depletion of zebrafish essential and regulatory myosin light chains reduces cardiac function through distinct mechanisms. Cardiovasc Res. 2008;79:97-108. doi: 10.1093/cvr/cvn073.
15. Berdougo E, Coleman H, Lee DH, Stainier DY, Yelon D. Mutation of weak atrium/atrial myosin heavy chain disrupts atrial function and influences ventricular morphogenesis in zebrafish. Development. 2003;130:6121-6129. doi: 10.1242/dev.00838.
16. Hassel D, Dahme T, Erdmann J, Meder B, Huge A, Stoll M, et al. Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy. Nat Med. 2009;15:1281-1288. doi: 10.1038/nm.2037.
17. Knöll R, Postel R, Wang J, Krätzner R, Hennecke G, Vacaru AM, et al. Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. Circulation. 2007;116:515-525. doi: 10.1161/CIRCULATIONAHA.107.689984.
18. Musso G, Tasan M, Mosimann C, Beaver JE, Plovie E, Carr LA, et al. Novel cardiovascular gene functions revealed via systematic phenotype prediction in zebrafish. Development. 2014;141:224-235. doi: 10.1242/dev.099796.
19. Yang J, Hartjes KA, Nelson TJ, Xu X. Cessation of contraction induces cardiomyocyte remodeling during zebrafish cardiogenesis. Am J Physiol Heart Circ Physiol. 2014;306:H382-H395. doi: 10.1152/ajpheart.00721.2013.
20. Becker JR, Robinson TY, Sachidanandan C, Kelly AE, Coy S, Peterson RT, et al. In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling. Cardiovasc Res. 2012;93:463-470. doi: 10.1093/cvr/cvr350.
21. Ding Y, Sun X, Huang W, Hoage T, Redfield M, Kushwaha S, et al. Haploinsufficiency of target of rapamycin attenuates cardiomyopathies in adult zebrafish. Circ Res. 2011;109:658-669. doi: 10.1161/CIRCRESAHA.111.248260.
22. Sun X, Hoage T, Bai P, Ding Y, Chen Z, Zhang R, et al. Cardiac hypertrophy involves both myocyte hypertrophy and hyperplasia in anemic zebrafish. PLoS One. 2009;4:e6596. doi: 10.1371/journal.pone.0006596.
23. Teekakirikul P, Kelly MA, Rehm HL, Lakdawala NK, Funke BH. Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era. J Mol Diagn. 2013;15:158-170. doi: 10.1016/j. jmoldx.2012.09.002.
24. Oka T, Xu J, Molkentin JD. Re-employment of developmental transcription factors in adult heart disease. Semin Cell Dev Biol. 2007;18:117-131. doi: 10.1016/j.semcdb.2006.11.012.
25. Abraham WT, Gilbert EM, Lowes BD, Minobe WA, Larrabee P, Roden RL, et al. Coordinate changes in myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Mol Med. 2002;8:750-760.
26. Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11:R106. doi: 10.1186/gb-2010-11-10-r106.
27. Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, et al. The DAVID gene functional classification tool: a novel biological modulecentric algorithm to functionally analyze large gene lists. Genome Biol. 2007;8:R183. doi: 10.1186/gb-2007-8-9-r183.
28. Lee JH, Gao C, Peng G, Greer C, Ren S, Wang Y, et al. Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts. Circ Res. 2011;109:1332-1341. doi: 10.1161/CIRCRESAHA.111.249433.
29. Ramsköld D, Wang ET, Burge CB, Sandberg R. An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data. PLoS Comput Biol. 2009;5:e1000598. doi: 10.1371/journal.pcbi.1000598.
30. Matkovich SJ, Zhang Y, Van Booven DJ, Dorn GW 2nd. Deep mRNA sequencing for in vivo functional analysis of cardiac transcriptional regulators: application to Galphaq. Circ Res. 2010;106:1459-1467. doi: 10.1161/CIRCRESAHA.110.217513.
31. Rajabi M, Kassiotis C, Razeghi P, Taegtmeyer H. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev. 2007;12:331-343. doi: 10.1007/s10741-007-9034-1.
32. Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013;10:531-547. doi: 10.1038/nrcardio.2013.105.
33. Chopra SS, Stroud DM, Watanabe H, Bennett JS, Burns CG, Wells KS, et al. Voltage-gated sodium channels are required for heart development in zebrafish. Circ Res. 2010;106:1342-1350. doi: 10.1161/CIRCRESAHA.109.213132.
34. Goonesinghe A, Luan XM, Hurlstone A, Garrod D. Desmosomal cadherins in zebrafish epiboly and gastrulation. BMC Dev Biol. 2012;12:1. doi: 10.1186/1471-213X-12-1.
35. Ton C, Hwang DM, Dempsey AA, Tang HC, Yoon J, Lim M, et al. Identification, characterization, and mapping of expressed sequence tags from an embryonic zebrafish heart cDNA library. Genome Res. 2000;10:1915-1927.
36. Ding Y, Liu W, Deng Y, Jomok B, Yang J, Huang W, et al. Trapping cardiac recessive mutants via expression-based insertional mutagenesis screening. Circ Res. 2013;112:606-617. doi: 10.1161/CIRCRESAHA.112.300603.
37. Murphy AM, Jones L 2nd, Sims HF, Strauss AW. Molecular cloning of rat cardiac troponin I and analysis of troponin I isoform expression in developing rat heart. Biochemistry. 1991;30:707-712.
38. Carniel E, Taylor MR, Sinagra G, Di Lenarda A, Ku L, Fain PR, et al. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation. 2005;112:54-59. doi: 10.1161/CIRCULATIONAHA.104.507699.
39. Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, Mc-Donough B, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med. 2000;343:1688-1696. doi: 10.1056/NEJM200012073432304.
40. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, et al. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest. 1997;100:2315-2324. doi: 10.1172/JCI119770.
41. Lompré AM, Nadal-Ginard B, Mahdavi V. Expression of the cardiac ventricular alpha-and beta-myosin heavy chain genes is developmentally and hormonally regulated. J Biol Chem. 1984;259:6437-6446.
42. Chen W, Burgess S, Hopkins N. Analysis of the zebrafish smoothened mutant reveals conserved and divergent functions of hedgehog activity. Development. 2001;128:2385-2396.
43. Lehman JJ, Kelly DP. Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth. Heart Fail Rev. 2002;7:175-185.
44. Postlethwait JH, Yan YL, Gates MA, Horne S, Amores A, Brownlie A, et al. Vertebrate genome evolution and the zebrafish gene map. Nat Genet. 1998;18:345-349. doi: 10.1038/ng0498-345.
45. Ramsköld D, Luo S, Wang YC, Li R, Deng Q, Faridani OR, et al. Fulllength mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol. 2012;30:777-782. doi: 10.1038/nbt.2282.
46. Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature. 2013;496:498-503. doi: 10.1038/nature12111.
47. Hu N, Yost HJ, Clark EB. Cardiac morphology and blood pressure in the adult zebrafish. Anat Rec. 2001;264:1-12.